These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2793971)

  • 1. Determination of cisplatin and related platinum complexes in plasma ultrafiltrate and urine by high-performance liquid chromatography with on-line radioactivity detection.
    Baldew GS; Volkers KJ; De Goeij JJ; Vermeulen NP
    J Chromatogr; 1989 Jun; 491(1):163-74. PubMed ID: 2793971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of 75Se-labelled selenite and metabolites in plasma and urine by high-performance liquid chromatography with on-line radioactivity detection.
    Baldew GS; De Goeij JJ; Vermemeulen NP
    J Chromatogr; 1989 Nov; 496(1):111-20. PubMed ID: 2592505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of platinum species originating from cis-diamminedichloroplatinum(II) (cisplatin) in human and rat plasma by high-performance liquid chromatography with on-line inductively coupled plasma atomic emission spectrometric detection.
    de Waal WA; Maessen FJ; Kraak JC
    J Chromatogr; 1987 Oct; 407():253-72. PubMed ID: 3429508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-performance liquid chromatographic determination of platinum (II) in plasma ultrafiltrate and urine: comparison with a flameless atomic absorption spectrometric method.
    Drummer OH; Proudfoot A; Howes L; Louis WJ
    Clin Chim Acta; 1984 Jan; 136(1):65-74. PubMed ID: 6319051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate.
    Brouwers EE; Tibben MM; Rosing H; Hillebrand MJ; Joerger M; Schellens JH; Beijnen JH
    J Mass Spectrom; 2006 Sep; 41(9):1186-94. PubMed ID: 16929560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative protein binding, stability and degradation of satraplatin, JM118 and cisplatin in human plasma in vitro.
    Bell DN; Liu JJ; Tingle MD; Rattel B; Meyer TU; McKeage MJ
    Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1440-6. PubMed ID: 18671714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model for ultrafilterable plasma platinum disposition in patients treated with cisplatin.
    Reece PA; Stafford I; Russell J; Khan M; Gill PG
    Cancer Chemother Pharmacol; 1987; 20(1):26-32. PubMed ID: 3621450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of antitumour [1,1-bis(aminomethyl)cyclohexane]platinum(II) complexes derived from spiroplatin by high-performance liquid chromatography with differential pulse amperometric detection.
    Elferink F; van der Vijgh WJ; Pinedo HM
    J Chromatogr; 1985 Mar; 320(2):379-92. PubMed ID: 4030937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sensitive postcolumn derivatization/UV detection system for HPLC determination of antitumor divalent and quadrivalent platinum complexes.
    Kizu R; Yamamoto T; Yokoyama T; Tanaka M; Miyazaki M
    Chem Pharm Bull (Tokyo); 1995 Jan; 43(1):108-14. PubMed ID: 7895301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of platinum-containing drugs in human plasma by liquid chromatography with reductive electrochemical detection.
    Parsons PJ; Morrison PF; LeRoy AF
    J Chromatogr; 1987 Jan; 385():323-35. PubMed ID: 3558589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high-performance liquid chromatographic assay with improved selectivity for cisplatin and active platinum (II) complexes in plasma ultrafiltrate.
    Andrews PA; Wung WE; Howell SB
    Anal Biochem; 1984 Nov; 143(1):46-56. PubMed ID: 6099065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of cisplatin and carboplatin with sodium thiosulfate: reaction rates and protein binding.
    Elferink F; van der Vijgh WJ; Klein I; Pinedo HM
    Clin Chem; 1986 Apr; 32(4):641-5. PubMed ID: 3513991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatographic determination of cisplatin as platinum(II) in a pharmaceutical preparation and blood samples of cancer patients.
    Khuhawar MY; Lanjwani SN; Memon SA
    J Chromatogr B Biomed Sci Appl; 1997 May; 693(1):175-9. PubMed ID: 9200532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenic activity and identification of excreted platinum in human and rat urine and rat plasma after administration of cisplatin.
    Safirstein R; Daye M; Guttenplan JB
    Cancer Lett; 1983 Apr; 18(3):329-38. PubMed ID: 6682696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a LC-MS/MS assay for quantification of cisplatin in rat plasma and urine.
    Shaik AN; Altomare DA; Lesko LJ; Trame MN
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1046():243-249. PubMed ID: 28162967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of ethylenediamineplatinum(II) malonate in infusion fluids, human plasma and urine by high-performance liquid chromatography.
    van der Vijgh WJ; Elferink F; Postma GJ; Vermorken JB; Pinedo HM
    J Chromatogr; 1984 Oct; 310(2):335-42. PubMed ID: 6511851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capillary liquid chromatography with UV detection using N,N-diethyl dithiocarbamate for determining platinum-based antitumor drugs in plasma.
    Otsuki Y; Kotani A; Kusu F
    Chem Pharm Bull (Tokyo); 2012; 60(5):665-9. PubMed ID: 22689405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel method for speciation of Pt in human serum incubated with cisplatin, oxaliplatin and carboplatin by conjoint liquid chromatography on monolithic disks with UV and ICP-MS detection.
    Martinčič A; Cemazar M; Sersa G; Kovač V; Milačič R; Ščančar J
    Talanta; 2013 Nov; 116():141-8. PubMed ID: 24148385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive estimation of bound and mobile platinum compounds in the kidney using a radiopharmacokinetic model.
    Brechner RR; D'Argenio DZ; Dahalan R; Wolf W
    J Pharm Sci; 1986 Sep; 75(9):873-7. PubMed ID: 3783454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake and metabolism of cisplatin by rat kidney.
    Safirstein R; Miller P; Guttenplan JB
    Kidney Int; 1984 May; 25(5):753-8. PubMed ID: 6540826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.